Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Carcinoma × Interleukin-2 × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Terminated 2 Unknown 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Melanoma 7 Breast Neoplasms 6 Leukemia, Myeloid, Acute 5 Ovarian Neoplasms 4 Neoplasm Metastasis 4 Colorectal Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Triple Negative Breast Neoplasms 3 Skin Neoplasms 3 Uterine Cervical Neoplasms 2 Stomach Neoplasms 2 Recurrence 2 Rectal Neoplasms 2 Neuroblastoma 2 Neoplasms 2 Multiple Myeloma 2 Lymphoma, Non-Hodgkin 2 Leukemia, Myeloid 2 Leukemia 2 Glioblastoma 2 Esophageal Neoplasms 2 Carcinoma, Merkel Cell 2 Uveal Melanoma 1 Urinary Bladder Neoplasms 1 Turcot syndrome 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumor 1 Select Advanced Solid Tumors 1 Sarcoma, Synovial 1 Sarcoma 1

Interventions

pembrolizumab 11 Cisplatin 11 Specimen Handling 8 Magnetic Resonance Spectroscopy 8 durvalumab 4 Platinum 4 Pemetrexed 4 Paclitaxel 4 Cyclophosphamide 4 1,2-diaminocyclohexaneplatinum II citrate 4 fludarabine 3 cemiplimab 3 Radiotherapy, Intensity-Modulated 3 Radiotherapy 3 Oxaliplatin 3 Nivolumab 3 Fluorouracil 3 Carboplatin 3 Biopsy 3 poly ICLC 2 osimertinib 2 cabozantinib 2 atezolizumab 2 Heavy Ion Radiotherapy 2 Gemcitabine 2 Drug Therapy 2 Docetaxel 2 Cetuximab 2 Capecitabine 2 zipalertinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05141474 2024-11-07

NEXTGENTIL-ACT

Vall d'Hebron Institute of Oncology

Phase EARLY_PHASE1 Recruiting

Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡